(Q52076226)

21 April 2018

title

Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione. (English)

1 reference

21 April 2018

author name string

K Lemma

1

1 reference

21 April 2018

J Berglund

2

1 reference

21 April 2018

N Farrell

3

1 reference

21 April 2018

L I Elding

4

1 reference

21 April 2018

publication date

1 June 2000

1 reference

21 April 2018

Journal of Biological Inorganic Chemistry

published in

1 reference

21 April 2018

volume

5

1 reference

21 April 2018

issue

3

1 reference

21 April 2018

page(s)

300-306

1 reference

21 April 2018

https://scigraph.springernature.com/pub.10.1007/pl00010658

exact match

0 references

cites work

Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.

1 reference

12 December 2020

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)

1 reference

12 December 2020

Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents

1 reference

12 December 2020

Promising new developments in cancer chemotherapy

1 reference

12 December 2020

In vitro biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma

1 reference

12 December 2020

Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione

1 reference

12 December 2020

Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans

1 reference

12 December 2020

Studies on the human metabolism of iproplatin

1 reference

12 December 2020

Does the antitumoral activity of platinum (IV) derivatives result from their in vivo reduction?

1 reference

12 December 2020

Glutathione-mediated activation of anticancer platinum(IV) complexes

1 reference

12 December 2020

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

1 reference

12 December 2020

Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry.

1 reference

12 December 2020

Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.

1 reference

12 December 2020

Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue

1 reference

12 December 2020

Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes

1 reference

12 December 2020

Current status of platinum-based antitumor drugs

1 reference

12 December 2020

Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA

1 reference

12 December 2020

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

12 December 2020

Synthesis, Structure, Biological Activity, and DNA Binding of Platinum(II) Complexes of the Type trans-[PtCl(2)(NH(3))L] (L = Planar Nitrogen Base). Effect of L and Cis/Trans Isomerism on Sequence Specificity and Unwinding Properties Observed in Glo

1 reference

12 December 2020

Activity of JM9 in advanced ovarian cancer: a phase I-II trial.

1 reference

12 December 2020

The Iron(III)-Catalyzed Oxidation of Cysteine by Molecular Oxygen in the Aqueous Phase. An Example of a Two-Thirds-Order Reaction

1 reference

12 December 2020

Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action

1 reference

12 December 2020

Identifiers

DOI

10.1007/PL00010658

1 reference

21 April 2018

1 reference

21 April 2018